CircRNA-MYLK might function as competing endogenous RNA (ceRNA) for miR-29a, which could contribute to EMT and the development of bladder carcinoma through activating VEGFA/VEGFR2 and downstream Ras/ERK signaling pathway.
Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway.